These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


460 related items for PubMed ID: 17495621

  • 1. Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice.
    Costello F, Stüve O, Weber MS, Zamvil SS, Frohman E.
    Curr Opin Neurol; 2007 Jun; 20(3):281-5. PubMed ID: 17495621
    [Abstract] [Full Text] [Related]

  • 2. Treatment and treatment trials in multiple sclerosis.
    Kieseier BC, Wiendl H, Hemmer B, Hartung HP.
    Curr Opin Neurol; 2007 Jun; 20(3):286-93. PubMed ID: 17495622
    [Abstract] [Full Text] [Related]

  • 3. Multiple sclerosis: new treatment trials and emerging therapeutic targets.
    DeAngelis T, Lublin F.
    Curr Opin Neurol; 2008 Jun; 21(3):261-71. PubMed ID: 18451708
    [Abstract] [Full Text] [Related]

  • 4. Getting specific: monoclonal antibodies in multiple sclerosis.
    Lutterotti A, Martin R.
    Lancet Neurol; 2008 Jun; 7(6):538-47. PubMed ID: 18485317
    [Abstract] [Full Text] [Related]

  • 5. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T, Bereczki D.
    Ideggyogy Sz; 2004 Nov 20; 57(11-12):401-16. PubMed ID: 15662768
    [Abstract] [Full Text] [Related]

  • 6. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience.
    Fassas A, Kimiskidis VK.
    J Neurol Sci; 2004 Aug 15; 223(1):53-8. PubMed ID: 15261561
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of interferon-beta in the treatment of multiple sclerosis.
    Derwenskus J, Lublin FD.
    Adv Neurol; 2006 Aug 15; 98():257-71. PubMed ID: 16400838
    [No Abstract] [Full Text] [Related]

  • 14. Knowns and unknowns in the future of multiple sclerosis treatment.
    Stüve O.
    J Neurol Sci; 2009 Dec 15; 287 Suppl 1():S30-6. PubMed ID: 20106346
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.